期刊文献+

树突状细胞制备脑胶质瘤疫苗的体外研究 被引量:4

下载PDF
导出
摘要 目的 通过体外实验探讨应用树突状细胞制备的肿瘤疫苗抗脑胶质瘤的作用机制。方法 培养大鼠树突状细胞,冻融法制备胶质瘤抗原,以肿瘤抗原致敏树突状细胞而制备胶质瘤疫苗。将实验动物分为4组,分别将胶质瘤疫苗、树突状细胞、生理盐水注入正常大鼠体内,到达预定时间取出大鼠脾脏,MTT法检测大鼠淋巴细胞活性。结果 1次输入胶质瘤疫苗的正常大鼠的淋巴细胞对肿瘤细胞的杀伤活性明显低于3次输入胶质瘤疫苗的正常大鼠;比较输入培养8d的树突状细胞和输入生理盐水的大鼠,其淋巴细胞对肿瘤细胞的杀伤活性无统计学差异。结论 应用树突状细胞制备胶质瘤疫苗可明显激活体内抗肿瘤免疫反应。
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2005年第2期149-151,共3页 Chinese Journal of Nervous and Mental Diseases
  • 相关文献

参考文献9

  • 1刘福生,王忠诚,历俊华,林松,任铭,肖庆,张亚卓.肿瘤抗原致敏树突状细胞瘤苗治疗颅内胶质瘤的实验研究[J].中华神经外科杂志,2002,18(2):91-95. 被引量:17
  • 2Yamanacement R, Zullo SA, Tanaka R, et al. Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki Forest virus-mediated complementary DNA. J Neurosurg, 2001, 94(3):474.
  • 3Mayordomo JI, Zorina T, Storkus WJ, et al. Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines.Stem Cells, 1997, 15(2):94.
  • 4Yamanaka R, Zullo SA, Ramsey J, et al. Marked enhancement of antitumor immune in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interlekin-12. J Neurosurg,2002, 97(3):611.
  • 5Akasaki Y, Kikuchi T, Homma S, et al. Antitumor effect of immunization with fusion of dendritic and glioma cells in a mouse brain tumor model. J Immunother, 2001, 24(2) : 106.
  • 6Nishioka Y, Hitao M, Robbins PD, et al. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res, 1999, 59(16) :4035.
  • 7Miller G, Lahrs S, Pillarisetty VG, et al. Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediared tumor protection. Cancer Res, 2002, 62(18) :5260.
  • 8Zhang W, He L, Yuan X, et al. Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin.Hum Gene Ther, 1999, 10(7):1151.
  • 9孟庆海,宫安静,李洛.树突状细胞的培养及其诱导的神经胶质瘤体外杀伤作用研究[J].中国神经精神疾病杂志,2004,30(3):182-185. 被引量:3

二级参考文献19

  • 1Sigal LJ,Reiser H,Rock KL.The role of B7-1and B7-2 costimulation for the generation of CTL rosponses in vitro.J Immunol,1998,161(6):2740.
  • 2Gabrilovich DI,Ciemik IF,Canbone DP.Dendritic cells in antitumor immune response.I.Defective antigen presentation in tunorbearing host.Cell Immunol,1996,170(1):101.
  • 3Hsu F,Benike C,Fagnoni F,et al.Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells.Nat Med,1996,36(2):52.
  • 4Nestle FO,Alijagic S,Gilliet M,et al.Vaccination of melanoma patients with peptide or tumor lysate-pulsed dendritic cells.Nat Med,1998,86(4):328.
  • 5Salgaller ML,Tjoa BA,Lodge PA,et al.Dendritic cell-based immunotherapy of prostate cancer.Crit Rev Immunol,t998,18(1):109.
  • 6Bancheresu J,Steinman RM.Dendritic cells and the control of immunity.Nature,1998,392(6673):245.
  • 7Roth MD,Gitilitz BJ,Kiertscher SM,et al.Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.Cancer Research,2000,60(7):1934.
  • 8Krause SW,Neumann C,Soruri A,et al.The treatment of patients with disseminated malignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells.J Immunother,2002,25(5):4.21.
  • 9Tjoa BA,Simmons SJ,Bowes VA,et al.Evaluation of Phase Ⅰ/Ⅱ clinical trials in prostate cancer with dendritic cells and PSMA peptides.Prostate,1998,36(6):39.
  • 10Scheinberg LC,Edelman FL,Levy WA.Is the brain "an immunologically privileged site?" I.Studies based on intracerebral homotransplantations and isotransplantation to sensitized hosts.Arch Neurol,1964,11(1):248.

共引文献17

同被引文献24

  • 1甄海宁,章翔,章薇,杨彤涛,白文涛,付洛安,胡世颉,潘灏,高大宽,王西玲.靶向Survivin基因的短发卡RNA对U251细胞生长和凋亡的影响[J].中华实验外科杂志,2006,23(1):72-74. 被引量:10
  • 2李春晖,焦保华,康春生,刘晓智.骨髓基质干细胞移植对大鼠胶质瘤局部微环境的影响[J].中国临床神经科学,2006,14(4):358-361. 被引量:3
  • 3李春晖,焦保华,康春生,刘晓智.骨髓间充质干细胞向脑胶质瘤趋向性的初步研究(英文)[J].中国神经精神疾病杂志,2006,32(4):289-293. 被引量:10
  • 4Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas[J].Cancer Res,2005,65:3307-3318
  • 5Chen Q, Long Y, Yuan X, et al. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors[J]. J Neurosci Res,2005,80:611-619
  • 6Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow[J]. Nature, 2002,418:41-49
  • 7Hermann A, Gastl R, Liebau S, et al. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells[J]. J Cell Sci, 2004,117:4411-4422
  • 8Takahashi Y, Cleary KR, Mai M, et al. Significance of Vesselcount and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer [ J ]. Cancer Res, 1996,2:1679 - 1684
  • 9Annabi B, Naud E, Lee YT, et al. Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors[J].J Cell Biochem,2004,91:1146-1158
  • 10Kinnaird T, Stabile E, Bumett MS, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms[J]. Circ Res,2004,94:678-685

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部